Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 231

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 231
---
.

At a meeting
of the Cerevast Board held on September 27, 2021, a review of potential target companies took place. At the time of this meeting, nine
different companies had been contacted and evaluated and four had expressed interest in a potential acquisition. During this meeting,
it was proposed by Mr. Wang that the search for target companies should be focused on those with products and services related to extending
and improving patient longevity.

| 114 |

On October 26,
2021, Longevity was incorporated in the State of Delaware and on November 4, 2021, Longevity retained Nelson Mullins Riley & Scarborough
LLP (“Nelson Mullins”) as its legal counsel.

At a meeting
of the Cerevast board held on December 2, 2021, it was agreed that FutureTech Partners LLC, an entity controlled by Mr. Wang, would provide
the necessary funding for legal, valuation, financial advisory and audit services related to completing a multi-company acquisition transaction
and a possible SPAC business combination.

In January 2022,
a non-binding term sheet was signed by five companies in connection with a multi- company acquisition transaction and a possible SPAC
business combination with an undetermined SPAC. Due diligence continued on each potential target company through June 2022 and in July
2022, Longevity entered into Contribution and Exchange Agreements (“C&E Agreements”) with each of Aegeria, Cerevast, Novokera
and WiCab China.

FutureTech, a blank check
company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization,
reorganization or other similar business combination with one or more businesses or entities, consummated its IPO in February 2022,
from which it derived gross proceeds of $115 million, including proceeds from the full exercise of the underwriters’
over-allotment option. Like most blank check companies, its FutureTech charter provides for the return of the IPO proceeds
held in trust to the holders of shares of common stock sold in the IPO if no qualifying business combinations are consummated on or
before a certain date (in FutureTech’s case, August 18, 2025).

After the FutureTech
IPO, FutureTech’s officers, advisors and directors commenced an active search for prospective businesses or assets to acquire in
its initial business combination. Representatives from the FutureTech management team contacted, and were contacted by,